Mint Solutions Holding BV, an Amsterdam, the Netherlands-based developer and marketer of a medication safety system, raised €5m in Series B equity funding.
The round was led by the Brabant Development Agency (BOM Capital) and existing shareholders LSP (Life Sciences Partners), investing from its LSP Health Economics Fund, and Seventure Partners. Other shareholders, including NSA Ventures and a number of private Icelandic investors, also participated in the financing.
The new funds will be used to support the rollout of Mint’s proprietary MedEye system.
Led by Gauti Reynisson, CEO, Mint Solutions is advancing MedEye, which aims to stop and prevent medication errors and improve efficiency in hospitals and care institutions. Through a combination of hardware and software and integration with hospital information systems, the system enables nurses to automatically verify medication at the bedside, thus ensuring that patients get the right medication, in the right dose and at the right time.